Randomized trial finds targeting individual metastases in oligometastatic breast cancer does not improve survival

Treating individual metastatic tumors with highly focused radiation or surgery did not improve progression-free or overall survival for patients with oligometastatic breast cancer receiving first-line systemic therapy, according to results from the randomized NRG-BR002 clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

Read it at Medical Xpress ↗

← Front page